NFE2L2 and Hepatic fibrosis: Another miRNA, miR-27 a/b, reduces prohibitin 1 and NRF2 (Yang et al. 2013) and leads to the appearance of non-alcoholic steatohepatitis-like symptoms and liver fibrosis.